Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine (Q40653694)

22 September 2017

Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine (English)

1 reference

22 September 2017

1 reference

3

1 reference

22 September 2017

5

Jacqueline M Katz

1 reference

22 September 2017

1

Rick A Bright

1 reference

22 September 2017

Ted M Ross

2

1 reference

PubMed ID

12706077

22 September 2017

Harriet L Robinson

series ordinal

4

1 reference

PubMed ID

12706077

22 September 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

22 September 2017

1 reference

22 September 2017

308

1 reference

22 September 2017

2

1 reference

22 September 2017

270-278

1 reference

Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998.

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype)

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

Continued circulation in China of highly pathogenic avian influenza viruses encoding the hemagglutinin gene associated with the 1997 H5N1 outbreak in poultry and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

H9N2 influenza viruses possessing H5N1-like internal genomes continue to circulate in poultry in southeastern China

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

Carbohydrates of influenza virus. V. Oligosaccharides attached to individual glycosylation sites of the hemagglutinin of fowl plague virus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

Attenuated and wild-type HIV-1 infections and long terminal repeat-mediated gene expression from plasmids delivered by gene gun to human skin ex vivo and macaques in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

Demonstration of Antibodies to Both Hemagglutinin and Neuraminidase Antigens of H3N2 Influenza A Virus in Domestic Dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

One-time gene gun or intramuscular rabies DNA vaccination of non-human primates: comparison of neutralizing antibody responses and protection against rabies virus 1 year after vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

Studies on antibody responses following neonatal immunization with influenza hemagglutinin DNA or protein

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

The antigenicity and evolution of influenza H1 haemagglutinin, from 1950-1957 and 1977-1983: two pathways from one gene

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

Characterization of H5N1 influenza viruses that continue to circulate in geese in southeastern China

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

Studies on the origin of pandemic influenza viruses V. Persistence of Asian influenza virus hemagglutinin (H2) antigen in nature?

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

The structure and function of the hemagglutinin membrane glycoprotein of influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

Structural basis of immune recognition of influenza virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

The structure and role of the carbohydrate moieties of influenza virus haemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

Antibody response in humans to influenza virus type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

Antibody-forming cell response to virus challenge in mice immunized with DNA encoding the influenza virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

Avirulent Avian influenza virus as a vaccine strain against a potential human pandemic.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900008-4

7 January 2021

10.1016/S0042-6822(03)00008-4

Identifiers

DOI

1 reference

22 September 2017

1 reference

PubMed ID

12706077